Patients with Generalized Lymphatic Anomaly (GLA) or Gorham-Stout Disease (GSD) develop ectopic lymphatics in bone and gradually lose bone. The process by which lymphatics invade bone is poorly understood.
On Thursday, June 18, at 12 noon ET (11am CT, 10am MT, 9am PT), Dr. Michael T. Dellinger will provide an overview of GLA and GSD, and discuss his latest research on the development of bone lymphatics in animal models of GLA and GSD in this free on-line Symposium: "Vanishing Act: Lymphatic Vessels and Disappearing Bones."
Registration is free and open to all thanks to LE&RN Supporting Members and Corporate Sponsors.
RSVP and register here.
About Dr. Michael T. Dellinger
Dr. Michael Dellinger is an Assistant Professor in the Departments of Surgery and Molecular Biology at UT Southwestern Medical Center. He is also a member of the Hamon Center for Regenerative Science and Medicine and is the Director of Research for the Lymphatic Malformation Institute. Dr. Dellinger completed his Ph.D. at the University of Arizona and his postdoctoral studies at UT Southwestern Medical Center. His lab focuses on identifying biomarkers and treatments for GLA, GSD, and kaposiform lymphangiomatosis. Find out more about Dr. Dellinger and his lab at utsouthwestern.edu/labs/dellinger.
LE&RN thanks the Supporting Members and Sponsors who make these programs possible. If you are not a Supporting Member, please join those who are making a difference. Become a Supporting Member today and ensure that LE&RN can continue this vital work.